click below
click below
Normal Size Small Size show me how
PharmTech Key Terms
key acronyms/common terms
| Question | Answer |
|---|---|
| C-I | drugs that have no recognized medical use in the U.S. |
| C-II | drugs that have high abuse potential, but have a currently accepted medical use in the U.S. |
| NACDS | National Association of Chain Drug Stores |
| DEA | Drug Enforcement Agency |
| AphA | American Pharmaceutical Association |
| NDC | national drug number that identifies drugs approved by the FDA |
| UPC code | tracking code on a product that is a barcode and can be scanned |
| COGS | cost of goods sold |
| wholesale cost | the amount the pharmacy pays for the item |
| AWP | average wholesale price |
| FDA | Food and Drug Administration |
| CE units | continuing education units required to maintain your license |
| MAR | Medication Administration Record |
| ASHP | American Society of Health-system Pharmacists |
| allowable charge | the maximum amount an insurance company will reimburse for a drug |
| invoice | information that identifies what was sent from and the cost charged by a supplier |
| net price | the list price minus any trade discount |
| inventory | products in the pharmacy that are for sale |
| perpetual inventory | inventory which is continually tracked so that you always have a current record of product on hand |
| MEC | minimum effective concentration |
| MTC | minimum toxic concentration |
| absorption | movement of drug from dosage formulation to the blood |
| active transport | movement of drug molecules across membranes by active means |
| additive effects | the increase in effect when two drugs of similar actions are taken |
| admixture | the resulting solution when a drug is added to a parenteral solution |
| agonist | drugs that activate receptors to accelerate or slow normal cell function |
| anhydrous | without water molecules |
| bioavailability | the relative amount of an administered dose that reaches general circulation and the rate that this occurs |
| bioequivalence | the comparison of bioavailability between two dosage forms |
| closed formulary | a limited list of approved medications |
| DEA number | required on all controlled drug prescriptions, identifies the prescriber |
| duration of action | the time the drug concentration is above the minimum effective concentration (MEC) |
| enterohepatic cycling | the transfer of drugs and their metabolites from the liver to the bile in the gallbladder and then into the intestine, and the back into circulation |
| first pass metabolism | the substantial degradation of a drug caused by enzyme metabolism in the liver before the drug reaches the systemic circulation |
| geometric dilution | mixing two powders of unequal quantity |
| glomerular filtration | blood filtering process of the kidneys |
| HEPA filter | high efficiency particulate air filter |
| hypertonic | a solution that has a greater osmolarity than blood |
| NDC | national drug code - number assigned by he manufacturer. First five digits indicate the manufacturer; the next four digits indicate the medication, its strength, and dosage form. The last two numbers indicate the package size. |
| OBRA'90 | federal act that mandates pharmacists to provide counseling on all new prescriptions |
| Orange Book | the common name for the FDA's Approved Drug Products |
| teratogenencity | the ability of a substance to cause abnormal fetal development |
| TPN | total parenteral nutrition solution |
| adverse effect | an unintended side effect of a medication that is negative or in some way injurious to a patient |
| alimentary tract | the organs from the mouth to the anus; the GI tract is a portion of the alimentary tract |
| ampule | sealed glass container with an elongated neck that must be snapped off |
| antagonist | a drug that binds with receptors but does not activate them |
| antibiotic | a substance which harms or kills microorganisms like bacteria or fungi |
| antidote | a drug that antagonizes the toxic effect of another drug |
| aqueous | water-based |
| aseptic technique | methods used that maintain the sterile conditions of a product |
| automated dispensing system | system in which medications are dispensed from an automated unit at the point of use |
| auxiliary label | label which can be affixed to a prescription container which contains specific warnings to assist patient compliance with taking medications |
| body surface area | measure used for medication dosing which takes into consideration a patient's height and weight; measured in square meters |
| concentration | the strength of a solution |
| conversions | the change from one unit of measure to another so that the amounts are equal |
| diluent | a solvent that dilutes a freeze-dried substance or dilutes a solution |
| extemporaneous compounding | on-demand preparation of a drug product |
| flow rate | the rate (in ml/hr or ml/min) at which a solution is administered to a patient |
| gauge | a measurement for needles; the higher the guage, the smaller the needle |
| HIPAA - Health Information Portability and Accountability Act | federal act that protect patients' privacy |
| hypotonic | a solution which has a lower osmolarity than blood |
| hypersensitivity | an abnormal sensitivity generally resulting in an allergic reaction |
| infusion | the gradual intravenous injection of a volume of fluid |
| isotonic | a solution which has the same osmolarity as blood |
| legend drug | any drug which requires a prescription |
| look-alikes | drug names that have similar appearance, especially when in written form |
| Material Safety Data Sheets (MSDS) | required notices for hazardous substances |
| meniscus | the curved surface of a column of liquid |
| milliequivalent (mEq) | a unit of measure for electrolytes in solution |
| parenteral | a route of administration to any organ outside of the alimentary tract |
| passive diffusion | the movement of drugs from an area of higher concentration to lower concentration |
| pharmaceutical alternative | drug products that contain the same active ingredients, but not necessarily in the same amount or same dosage form |
| pharmaceutical equivalent | drug products that contain identical amounts of the same active ingredients in the same dosage form |
| signa | the directions for use on a prescription |
| solvent | a liquid that dissolves another substance in it |
| therapeutic equivalent | pharmaceutical equivalents that produce the same effects in patients |